Ottawa biotech firm Avivagen’s revenues slip on mistimed sales cycle
Local biotech firm Avivagen hit a snag in revenues this past quarter even as the firm continues to secure regulatory approvals for its alternative to
Ottawa biotech firm Avivagen’s revenues slip on mistimed sales cycle
Local biotech firm Avivagen hit a snag in revenues this past quarter even as the firm continues to secure regulatory approvals for its alternative to
Ottawa biotech firm Avivagen closes $5.3M financing amid U.S. market push
An Ottawa-based biotech firm that makes a line of natural health products designed to replace antibiotics in livestock feed has announced a multimillion-dollar funding round
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored
No poach clauses: Protect your workforce
Understanding search and seizure laws
Expanding Your business in the USA today?